PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Clinical trial NCT06607627 · RECRUITING
Trial details
- NCT number
- NCT06607627
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2026-12-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.